Skip to main content

DEA COVID-19 Information Page

Description
Guidance for DEA-registered telehealth practitioners to issue prescriptions for controlled substances to patients for whom they have not conducted an in-person medical evaluation, for the duration of the COVID-19 public health emergency.
Date
2020
Type
Website
Organizations
Drug Enforcement Administration, U.S. Department of Justice
Tagged as
Illicit drug use · Infectious diseases · Legislation and regulations · Pharmacy and prescription drugs · Prescription drug misuse · Substance use and misuse · Telehealth